Picture EBD Group Global Partnering Four Events One Price 650x80
Organisation › Details

Overland ADCT BioPharma (CN)

Overland ADCT BioPharma, a joint venture created by Overland Pharmaceuticals and ADC Therapeutics, is developing and commercializing four of ADC Therapeutics’ antibody drug conjugate (ADC) product candidates for difficult-to-treat hematologic and solid tumors – loncastuximab tesirine (Lonca), ADCT-601, ADCT-602 and ADCT-901 – in greater China and Singapore. *


Period Start 2021-04-06 existent jv
  Group Overland Pharmaceuticals (Group)
Products Industry antibody-drug conjugate (ADC)
  Industry 2 loncastuximab tesirine (ADCT-402)
Person Person Koo, Eric (Overland Pharmaceuticals 202104– CEO of Overland ADCT BioPharma before Takeda China + MSC Taiwan + Bayer)
Region Region Shanghai
  Country China
  City n. a. 
    Address record changed: 2021-04-09
Basic data Employees n. a.
    * Document for �About Section�: ADC Therapeutics S.A.. (4/6/21). "Press Release: Overland ADCT BioPharma Appoints Eric Koo as Chief Executive Officer". Boston, MA, Shanghai & Lausanne.
Record changed: 2021-04-09


Picture Berlin Partner Hotspot for Startups 650x80px

More documents for Overland Pharmaceuticals (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Excelya CRO Quality Agility for Your Research 650x80px

» top